To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.
Latest action · Jul 9, 2020 Referred to the House Committee on Ways and Means.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 9, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
This bill allows a new research tax credit amount for 14% of specified medical research expenditures. It defines specified medical research expenditures as amounts paid for any qualified research with respect to any qualified countermeasure. A qualified countermeasure is a drug, biological product, or device that is determined to be a priority (1) to diagnose, mitigate, prevent, or treat harm from any biological agent (including organisms that cause an infectious disease) or toxin, chemical, radiological, or nuclear agent that may cause a public health emergency affecting national security; (2) to diagnose, mitigate, prevent, or treat harm from a condition that may result in adverse health consequences or death and may be caused by administering a drug, biological product, or device; or (3) is a product or technology intended to enhance the use or effect of a drug, biological product, or device.
The bill also sets forth a special rule for treatment of specified medical research expenditures paid or incurred in taxable years beginning before January 1, 2021.
Cosponsors
Members who signed on, in the order they did.
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Ways and Means Committee | Referred Jul 9, 2020 |
| Tax Subcommittee | Referred Jul 9, 2020 |
Actions 3
Everything that happened, newest first.
- Jul 9, 2020Introduced in House
- Jul 9, 2020Referred to the Subcommittee on Select Revenue Measures.
- Jul 9, 2020Referred to the House Committee on Ways and Means.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 124, July 9, 2020, page H3078.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 14 | Commitment to Defeat the Virus and Keep America Healthy Act | Related bill | Nov 2, 2020 |
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.
Subjects
Assigned by the Library of Congress. Policy area: Taxation.
- Chemical and biological weapons
- Drug therapy
- Emergency medical services and trauma care
- Hazardous wastes and toxic substances
- Health technology, devices, supplies
- Income tax credits
- Infectious and parasitic diseases
- Medical research
- Medical tests and diagnostic methods
- Nuclear weapons
- Research and development
- Taxation
Text 1
Each version as it was printed, newest first.
- Jul 9, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.